These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16037266)

  • 1. Advanced glycation in health and disease: role of the modern environment.
    Vlassara H
    Ann N Y Acad Sci; 2005 Jun; 1043():452-60. PubMed ID: 16037266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Matsui T; Inoue H; Takeuchi M
    Med Hypotheses; 2007; 69(3):666-8. PubMed ID: 17331665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycosylation end products and nutrition--a possible relation with diabetic atherosclerosis and how to prevent it.
    Xanthis A; Hatzitolios A; Koliakos G; Tatola V
    J Food Sci; 2007 Oct; 72(8):R125-9. PubMed ID: 17995617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end product homeostasis: exogenous oxidants and innate defenses.
    Vlassara H; Uribarri J; Cai W; Striker G
    Ann N Y Acad Sci; 2008 Apr; 1126():46-52. PubMed ID: 18448795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible link of food-derived advanced glycation end products (AGEs) to the development of diabetes.
    Yamagishi S; Matsui T; Nakamura K
    Med Hypotheses; 2008 Dec; 71(6):876-8. PubMed ID: 18783891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products and diabetic foot disease.
    Huijberts MS; Schaper NC; Schalkwijk CG
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S19-24. PubMed ID: 18442180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults.
    Gugliucci A; Kotani K; Taing J; Matsuoka Y; Sano Y; Yoshimura M; Egawa K; Horikawa C; Kitagawa Y; Kiso Y; Kimura S; Sakane N
    Ann Nutr Metab; 2009; 54(3):197-201. PubMed ID: 19420913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycation, carbonyl stress, EAGLEs, and the vascular complications of diabetes.
    Lyons TJ
    Semin Vasc Med; 2002 May; 2(2):175-89. PubMed ID: 16222609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of advanced glycation end-products with glutathione status.
    Sahin E; Göçmen AY; Koçak H; Tuncer M; Gümüslü S
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):369-74. PubMed ID: 18583621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.
    Cameron NE; Gibson TM; Nangle MR; Cotter MA
    Ann N Y Acad Sci; 2005 Jun; 1043():784-92. PubMed ID: 16037306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
    Nishizawa Y; Koyama H
    J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylglyoxal, advanced glycation end products and autism: is there a connection?
    Maher P
    Med Hypotheses; 2012 Apr; 78(4):548-52. PubMed ID: 22325990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Kandaraki E; Piouka A; Papavassiliou AG; Panidis D
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):634-41. PubMed ID: 18363886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing.
    Yan SF; Yan SD; Herold K; Ramsamy R; Schmidt AM
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):511-24, viii. PubMed ID: 16959583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.
    Miyata T; Yamamoto M; Izuhara Y
    Ann N Y Acad Sci; 2005 Jun; 1043():740-9. PubMed ID: 16037301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction of pyridoxamine with malondialdehyde: mechanism of inhibition of formation of advanced lipoxidation end-products.
    Kang Z; Li H; Li G; Yin D
    Amino Acids; 2006 Feb; 30(1):55-61. PubMed ID: 15990947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects.
    Uribarri J; Stirban A; Sander D; Cai W; Negrean M; Buenting CE; Koschinsky T; Vlassara H
    Diabetes Care; 2007 Oct; 30(10):2579-82. PubMed ID: 17496238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.